...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors
【24h】

Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors

机译:新型STAT3途径抑制剂-含吡唑的1,2,4-三唑-[3,4-b]噻二嗪的优化

获取原文
获取原文并翻译 | 示例
           

摘要

Structure-activity relationship studies of a 1,2,4-triazolo-[3,4-b] thiadiazine scaffold, identified in an HTS campaign for selective STAT3 pathway inhibitors, determined that a pyrazole group and specific aryl substitution on the thiadiazine were necessary for activity. Improvements in potency and metabolic stability were accomplished by the introduction of an a-methyl group on the thiadiazine. Optimized compounds exhibited anti-proliferative activity, reduction of phosphorylated STAT3 levels and effects on STAT3 target genes. These compounds represent a starting point for further drug discovery efforts targeting the STAT3 pathway. (C) 2016 Elsevier Ltd. All rights reserved.
机译:在HTS运动中针对选择性STAT3途径抑制剂确定的1,2,4-三唑并-[3,4-b]噻二嗪支架的结构活性关系研究确定,噻二嗪上的吡唑基和特定的芳基取代是必要的活动。通过在噻二嗪上引入α-甲基来实现效力和代谢稳定性的改善。优化的化合物具有抗增殖活性,磷酸化的STAT3水平降低以及对STAT3目标基因的影响。这些化合物代表了针对STAT3途径的进一步药物发现努力的起点。 (C)2016 Elsevier Ltd.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号